← Eichor
Study identifier: NCT04723485 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood

Condition: Obsessive-compulsive Disorder  ·  Sponsor: Susanne Walitza

PhaseN/A
Planned participants625
Who can joinAll sexes, 4 Years to 18 Years
Healthy volunteersNo

About this study

Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.  ·  +41 (0)43 499 26 26  ·  susanne.walitza@puk.zh.ch

Juliane Ball, Dr. rer. Nat. Dipl. Psych  ·  +41 43 499 26 26  ·  juliane.ball@puk.zh.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Psychiatric University Clinics, Department of Child and Adolescent PsychiatryZurich, Canton of Zurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04723485